Kerri Morrone Sparling reviews the 2nd annual Roche Social Media Summit – and the real change put into action as a result of the first Summit.

Former ADA President Dr. John Buse offers a take on the ADA and FDA and weighs in on the current regulatory environment and healthcare reform.

One of the most talked-about announcements at the European Association for the Study of Diabetes (EASD) was a new blood glucose monitor that will connect to the iPhone...

Check out our latest pump and CGM learnings...

The 2007 AADE in August in St. Louis was extremely educational, as always.

Lessons from TCOYD, Santa Clara.

How can we best tackle diabetes and obesity? Read about our trip to the International Diabetes Federation’s 21st World Congress in Dubai.

Our impression of the keynote talk from Dr. Richard Kahn, Chief Scientific and Medical Officer of the ADA.

This winter we flew down to sunny Cape Town to attend the nineteenth official meeting of International Diabetes Federation (IDF).

The Obesity Society's annual meeting has long been our favorite place to catch up on the basic science research behind this critical problem.

The diaTribe team traveled to Amsterdam to attend the 43rd Annual Meeting of the European Association for the Study of Diabetes (EASD).

While the rest of America was watching the Super Bowl, we were taking in the countryside in Montpellier, France, at first annual European Diabetes Technology and...

We always love attending the ADA Postgrad meeting – an update for doctors and nurses on new practices in diabetes.

In late June, diaTribe sent our team to Chicago to attend the 67th Annual Scientific Sessions of the American Diabetes Association.

Main themes from AACE.

Click to learn exciting news on the artificial pancreas, faster insulins, and the results of the much-anticipated ORIGIN trial.

Our trip to Orlando brings smart, actionable advice on preventing high and low blood sugars from diabetes guru and educator Mr. Gary Scheiner.

The 30th Annual Obesity Society Meeting brings exciting insights on drugs and mobile health.

Our trip to Berlin brought new insights on implantable GLP-1, the latest in CGM and the artificial pancreas, and debates on early insulin therapy.

The 2012 Diabetes Technology Meeting provides new insights into the artificial pancreas and the latest thinking on regulation from the FDA.